Lipitor Buyers Ask 3rd Circ. To Keep Pay-For-Delay Fight
Attorneys for national pharmacies and wholesale drug distributors told the Third Circuit on Tuesday that their dismissed suit accusing Pfizer and Ranbaxy of a pay-for-delay scheme over the cholesterol drug Lipitor...To view the full article, register now.
Already a subscriber? Click here to view full article